Technology 7 September 2020 By Donna Lu These transparent solar panels have a brown or grey tintUbiQd Ordinary glass panels can act as solar panels when a layer of nanoparticles is sandwiched between two panes, which could help take advantage of solar energy in cities where space for solar panels may be limited. “If we’ve…
Taxis should operate with windows slightly opened, in an attempt to reduce the spread of Covid-19.Windows of vehicles are not expected to be opened wide. However, government wants fresh air to enter inside taxis that are in motion.Taxi operators are also called on to ensure that all passengers are wearing masks and that their hands…
By Donna Lu A grid of speakers facing outwards can play sounds that cancel out traffic noisesDanil Roudenko / Alamy People living in cities with warm climates face a dilemma during summer months: keeping the windows open lets in fresh air, but with it comes the sound of traffic. A noise-cancelling device now allows for…
By Adam Vaughan Windows filled with water can keep houses coolMatyas Gutai Buildings with windows filled with water rather than gas could save energy in most of the world, according to researchers backing the new technology. Matyas Gutai at Loughborough University, UK, believes the traditional approach to windows has gone as far as it can…
Technology 27 April 2020 By Leah Crane Let the light in – but not too muchbaona / Getty Smart windows that take into account the sun’s height in the sky could adjust how much light gets in to your home over the course of the seasons, helping regulate the temperature and lower energy requirements for…
The FDA has cleared the interleukin (IL)-23 inhibitor tildrakizumab (Ilumya) for the treatment of active psoriatic arthritis (PsA) in adults. Sun Pharma announced the approval on October 30. “As an IL-23 inhibitor administered exclusively by a healthcare provider, Ilumya is now an option for adults with active psoriatic arthritis who are unable to self-administer treatment
Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.
You don't have permission to access "http://www.medpagetoday.com/washington-watch/washington-watch/123652" on this server. Reference #18.d494d817.1793332899.22e6a54f https://errors.edgesuite.net/18.d494d817.1793332899.22e6a54f